Search results
1 – 10 of 234David Branford, David Gerrard, Nigget Saleem, Carl Shaw and Anne Webster
The STOMP programme – stopping the over-medication of people with an intellectual disability, autism or both is a three-year programme supported by NHS England. Concern about the…
Abstract
Purpose
The STOMP programme – stopping the over-medication of people with an intellectual disability, autism or both is a three-year programme supported by NHS England. Concern about the overuse of antipsychotic drugs has been a constant theme since the 1970s. However, despite a multitude of guidelines the practice continues. The report into the events at Winterbourne View not only raised concerns about the overuse of antipsychotic drugs but of antidepressants. Part 1 presented the historical background to the use of psychotropic drugs for people with an intellectual disability, autism or both. The purpose of this paper (Part 2) is to present the approach adopted to reduce over-medication (the “Call to Action”) and the progress so far at the half way stage.
Design/methodology/approach
The “Call to Action” methodology is described in a Manchester University report – mobilising and organising for large-scale change in healthcare “The Right Prescription: A Call to Action on the use of antipsychotic drugs for people with dementia”. Their research suggested that a social mobilising and organising approach to change operates could provide a mechanism for bringing about change where other approaches had failed.
Findings
The adoption of the “Call to Action” methodology has resulted in widespread acknowledgement across intellectual disability practice that overuse of psychotropic medication and poor review was resulting in over-medication. Many individual local programmes are underway (some are described in this paper) however to what extent the overall use of psychotropic drugs has changed is yet to be evaluated.
Originality/value
STOMP is part of an English national agenda – transforming care. The government and leading organisations across the health and care system are committed to transforming care for people with intellectual disabilities autism or both who have a mental illness or whose behaviour challenges services. This paper describes a new approach to stopping the over-medication of people with an intellectual disability, autism or both.
Details
Keywords
This commentary aims to define STOMP and STAMP, describes its history and evolution and the authors’ thoughts about future directions given the lack of clear evidence base for…
Abstract
Purpose
This commentary aims to define STOMP and STAMP, describes its history and evolution and the authors’ thoughts about future directions given the lack of clear evidence base for prescribing and deprescribing psychotropic medication given for behaviour thought to be challenging.
Design/methodology/approach
This commentary defines the authors’ clinical experience and personal thoughts about STOMP achievements and challenges for the future delivery.
Findings
This commentary details STOMP development to date and highlights the potential areas for further study and research to grow understanding, professional confidence and delivery.
Research limitations/implications
This commentary highlights much of the currently accepted research and areas that have poor quality evidence or are of interest for future study. STOMP definition, especially of inappropriate prescribing, is key to redefining the work.
Practical implications
This commentary highlights the potential impact of STOMP and STAMP on prescribing rates and the need for better definition, processes and education for workforce development. There is a major need to understand the benefit of behavioural intervention to support the optimisation of medication.
Originality/value
This commentary builds on personal experience and current understanding to postulate considerations to further the delivery of STOMP and STAMP.
Details
Keywords
David Branford, David Gerrard, Nigget Saleem, Carl Shaw and Anne Webster
The programme – Stopping the over-medication of people with an intellectual disability, Autism or Both (STOMP) is a three-year programme supported by NHS England. Concern about…
Abstract
Purpose
The programme – Stopping the over-medication of people with an intellectual disability, Autism or Both (STOMP) is a three-year programme supported by NHS England. Concern about the overuse of antipsychotic drugs has been a constant theme since the 1970s. However, despite a multitude of guidelines the practice continues. The report into the events at Winterbourne View not only raised concerns about the overuse of antipsychotic drugs but of antidepressants and multiple psychotropic drug use. The purpose of this paper is twofold: Part 1 is to present the history and background to the use of psychotropic drugs in intellectual disabilities, autism or both; and Part 2 presents the progress with the STOMP programme.
Design/methodology/approach
The review tracks the various concerns, guidelines and attempts to tackle the issue of over medication of people with intellectual disability autism or both.
Findings
The review identifies that despite the many studies and guidelines associated with the prescribing of psychotropic drugs for people with an intellectual disability, autism or both the practice is common. Programmes that minimise the use of psychotropic drugs involve a full use of the multidisciplinary team and an availability of alternative methods of managing challenging behaviours.
Originality/value
STOMP is part of an English national agenda – Transforming care. The English Government and leading organisations across the health and care system are committed to transforming care for people with intellectual disabilities, autism or both who have a mental illness or whose behaviour challenges services. This review identifies many studies, programmes and guidelines associated with psychotropic drug use for people with an intellectual disability, autism or both.
Details
Keywords
ZiJian Tian, XiaoWei Gong, FangYuan He, JiaLuan He and XuQi Wang
To solve the problem that the traditional received signal strength indicator real-time location method does not test the attenuation characteristics of the electromagnetic wave…
Abstract
Purpose
To solve the problem that the traditional received signal strength indicator real-time location method does not test the attenuation characteristics of the electromagnetic wave transmission in the location area, which cannot guarantee the accuracy of the location, resulting in a large location error.
Design/methodology/approach
At present, the compressed sensing (CS) reconstruction algorithm can be roughly divided into the following two categories (Zhouzhou and Fubao, 2014; Lagunas et al., 2016): one is the greedy iterative algorithm proposed for combinatorial optimization problems, which includes matching pursuit algorithm (MP), positive cross matching tracking algorithm (OMP), greedy matching tracking algorithm, segmented orthogonal matching tracking algorithm (StOMP) and so on. The second kind is the convex optimization algorithm, which also called the optimization approximation method. The common method is the basic tracking algorithm, which uses the norm instead of the norm to solve the optimization problem. In this paper, based on the piecewise orthogonal MP algorithm, the improved StOMP reconstruction algorithm is obtained.
Findings
In this paper, the MP algorithm (OMP), the StOMP and the improved StOMP algorithm are used as simulation reconstruction algorithms to achieve the comparison of location performance. It can be seen that the estimated position of the target is very close to the original position of the target. It is concluded that the CS grid-based target stepwise location method in underground tunnel can accurately locate the target in such specific region.
Originality/value
In this paper, the offline fingerprint database in offline phase of location method is established and the measurement of the electromagnetic noise distribution in different localization areas is considered. Furthermore, the offline phase shares the work of the location process, which greatly reduces the algorithm complexity of the online phase location process and the power consumption of the reference node, meanwhile is easy to implement under the same conditions, as well as conforms to the location environment.
Details
Keywords
Sadia Zahid, Bushra Rauf, Rachel Lee, Hafsa Sheikh, Ashok Roy and Rani Pathania
A quantitative observational study was conducted. The purpose of this study is to examine the continuing adherence to the stopping over-medication of people with intellectual…
Abstract
Purpose
A quantitative observational study was conducted. The purpose of this study is to examine the continuing adherence to the stopping over-medication of people with intellectual disability and/or autism guidelines for a cohort of outpatients seen in the outpatients’ clinics in the two teams who participated in this study to review the trend of psychotropic prescribing with a prescription indication along with the utilisation of non-pharmacological interventions.
Design/methodology/approach
Data was retrospectively collected over a period of one year for patients sampled conveniently in the outpatient’s clinic. The data was collected from two sites from psychiatric letters to the general practitioners (GPs), with the focus being psychotropic prescription indication and their adherence to British National Formulary limits, inclusion of a wider multi-disciplinary team or MDT (including nurses, psychologists and health support workers), use of Clinical Global Impression (CGI) scale for assessing medication side effects and response to treatment.
Findings
Most of the patients had at least one review in the previous six months. Antipsychotics were the highest prescribed medications without an indication for their use (13.3%) followed by anxiolytics and other medications. CGI recording was suboptimal, with 26% of the patient population did not have medication side effects and effectiveness monitored through this method. In total, 41% of patients were open to community nurses followed by other disciplines.
Originality/value
To the best of the authors’ knowledge, this is an original article following the pilot study completed by the authors.
Details
Keywords
Jon Painter, Winola Chio, Liam Black and David Newman
This study aims to understand whether psychotropic prescribing practices for people with intellectual disabilities are in keeping with best practice guidelines.
Abstract
Purpose
This study aims to understand whether psychotropic prescribing practices for people with intellectual disabilities are in keeping with best practice guidelines.
Design/methodology/approach
This service evaluation project was a retrospective analysis of routinely collected data from the care records of all 36 people with intellectual disability discharged from an intellectual disability assessment and treatment unit during the first five years of the Stop Over medicating People with Intellectual Disabilities and/or autistic people (STOMP) initiative. Data were gathered at four time points (pre-admission, discharge, 6- and 12-month follow-up) before being analysed to understand whether psychotropic prescribing differed among people with different clinical characteristics/traits/diagnoses. Changes over time were also explored to ascertain whether and how prescribing altered from admission to discharge, and over the subsequent year of community living.
Findings
Most people with intellectual disabilities left the assessment and treatment unit on fewer regular psychotropic medications and at lower doses than at admission. These optimised regimes were still apparent 12 months post-discharge, suggesting effective discharge planning and community care packages. Inpatients with severe intellectual disabilities generally received more anxiolytics and hypnotics, at higher doses. Autistic people tended to receive more psychotropics in total and at higher cumulative doses, a pattern that persisted post discharge. A third of the sample were admitted on regular anti-psychotic medications despite having no corresponding psychotic diagnosis, a proportion that remained relatively stable through discharge and into the community.
Originality/value
This study highlights subsets of the intellectual disability population at particular risk of receiving high doses of psychotropics and a feasible template for providers intending to undertake STOMP-focused evaluations.
Details
Keywords
This lesson plan is an introduction to the Harlem Renaissance through the award winning, thorough, resource text for youth, Harlem Stomp! A Cultural History of the Harlem…
Abstract
This lesson plan is an introduction to the Harlem Renaissance through the award winning, thorough, resource text for youth, Harlem Stomp! A Cultural History of the Harlem Renaissance by Laban Carrick Hill. The Harlem Borough was a place in New York where African Americans migrated and overtly celebrated their cultural capital and rich heritage from the turn of the Twentieth Century through the nineteen forties. Countless artists, writers, poets, musicians, philosophers, and intellectuals contributed to landscape which left an indelible historical identity. Equality and justice characterized the era, continued to influence the country through civil rights, and persists to the present day
David Gerrard, Jennifer Rhodes, Ruth Lee and Jonathan Ling
The purpose of this paper is to investigate if positive behavioural support (PBS) can be an effective alternative to medication, and can aid medication reduction in people with a…
Abstract
Purpose
The purpose of this paper is to investigate if positive behavioural support (PBS) can be an effective alternative to medication, and can aid medication reduction in people with a learning disability, autism or both who are prescribed psychotropic medication for behaviour thought to be challenging. STOMP is an initiative supported by NHS England which aims to reduce inappropriate prescribing of psychotropic medication, i.e. antipsychotics used for challenging behaviour in the absence of a documented mental health diagnosis. PBS has been described as the first line of intervention for behaviours which challenge, (NICE, 2015) and has been highlighted as a non-pharmacological alternative to, medication.
Design/methodology/approach
A two-group, experimental design was utilised. Both groups were considered for medication reduction. The experimental group of 25 people received input from a specialist PBS team, while the control group of 29 people underwent unsupported medication challenge.
Findings
There was a significantly higher success rate for medication reduction and discontinuation when PBS assessment and intervention was provided as an alternative to medication.
Practical implications
This study indicates that providing PBS is associated with decreased medication and if replicated should be become standard practice for specialist teams.
Originality/value
This is the first study to investigate the effect of PBS on medication reduction in patients prescribed psychotropic medication for behaviour thought to be challenging.
Details
Keywords
The purpose of this paper is to provide a commentary on the article by Lee and colleagues, entitled “Positive Behavioural Support as an alternative to medication”, from the…
Abstract
Purpose
The purpose of this paper is to provide a commentary on the article by Lee and colleagues, entitled “Positive Behavioural Support as an alternative to medication”, from the perspective of Dimensions, a national provider of social care support to people with learning disabilities and/or autism. As a supporter of the NHS England STOMP campaign, Dimensions recognises that people with learning disabilities and/or autism who have displayed “challenging behaviours” are at risk of being wrongly or over prescribed psychotropic medications intended to control that behaviour, and encourages the use of non-medical support strategies as an effective alternative to psychotropic medications.
Design/methodology/approach
Dimensions surveyed the approximately 1,400 people with learning disabilities and/or autism for whom they provide 24-h support. The survey was intended to assess the extent of use of psychotropic medications and the level of adherence to NICE “best practice” guidelines. The survey was the precursor to an awareness raising campaign and development of an operational toolkit intended to inform and empower people supported, families and colleagues to take a more proactive role in the prescription and review of psychotropic medications.
Findings
In total, 54 per cent of people surveyed were being prescribed psychotropic medication, of whom 97 per cent had been prescribed one or more medications for at least six months. Around 51 per cent were having six monthly multi-disciplinary reviews and around 31 per cent had not had a multi-disciplinary review within the preceding 12 months. Only 13 per cent of people taking psychotropic medication had a plan in place that was specifically aimed at reducing or stopping the medication.
Originality/value
Empowering people to participate in and challenge clinical decision making can have a transformative effect on the lives of a group of people who have experienced a significant negative impact from prolonged use of psychotropic medications.
Details
Keywords
Ruth M. Lee, Jennifer A. Rhodes and David Gerrard
The purpose of this paper is to demonstrate how Positive Behavioural Support (PBS) can be used as an alternative to psychotropic medication to improve the quality of life of an…
Abstract
Purpose
The purpose of this paper is to demonstrate how Positive Behavioural Support (PBS) can be used as an alternative to psychotropic medication to improve the quality of life of an individual with a learning disability and behaviour described as challenging.
Design/methodology/approach
A single case design was utilised. A unique PBS stopping over medication of people with a learning disability, autism or both (STOMP) clinic model was developed and PBS was used in line with National Institute for Health and Care Excellence (NICE) guidance. This included functional behavioural assessment, to support understanding of the reasons behind behaviour described as challenging, and a gradual medication reduction.
Findings
This case study found that antipsychotic medication used to manage behaviour that challenges could be safely reduced and individual quality of life increased when PBS was used as an alternative.
Originality/value
STOMP is a project supported by NHS England aimed at reducing the inappropriate prescribing of psychotropic medication to manage behaviour that challenges. NICE guidance recommends that behaviour should be more appropriately understood through PBS. More research is needed to demonstrate how the two work together for safe medication reduction and improved quality of life.
Details